HealthPlus Retail Group Business Plan › Section 4 › Competitive Landscape & Positioning

4.1 Market Structure

The South African pharmaceutical retail market is structurally
bifurcated between two dominant national chains, a small middle tier of
supermarket-anchored pharmacies, and a large but fragmented base of
independent operators. As at the end of 2024, the formal retail market
is distributed approximately as follows:

Figure 4.1

The two listed chains — Clicks Group (32.4% share) and Dis-Chem
Pharmacies (25.8% share) — together control 58.2% of formal market
revenue. The remaining 41.8% is divided between independents (22.1%),
supermarket-anchored pharmacies (Pick n Pay Pharmacy, Medirite/Shoprite,
collectively 11.2%), buying groups (Alpha Pharm, 5.7%), and other small
chains (2.8%). This fragmentation in the long tail is the consolidation
opportunity that HealthPlus will pursue.

4.2 Competitor Profiles

4.2.1 Clicks Group Limited (JSE: CLS)

Clicks operates approximately 920 pharmacy stores (and approaching
1,200 retail front-shop locations including non-pharmacy formats) across
South Africa, with smaller footprints in Botswana, Namibia, Eswatini,
and Lesotho. Clicks is the benchmark operator: it has demonstrated
sustained mid-teen ROE, a private-label penetration of approximately 23%
of own-brand sales, and a ClubCard loyalty programme with over 11
million active members. Strengths include scale, brand recognition, and
supply chain efficiency. Vulnerabilities include premium pricing on core
baskets and a footprint concentrated in higher-LSM mall locations.

4.2.2 Dis-Chem Pharmacies Limited (JSE: DCP)

Dis-Chem operates approximately 280 pharmacy stores in larger format
than Clicks, with a heavier wellness, supplements, and clinical-services
tilt. Dis-Chem differentiates on category breadth (particularly
vitamins, supplements, and sports nutrition) and on family-orientated
marketing. Its loyalty programme (Benefit) has approximately 8 million
members. Pricing is generally aligned with Clicks; Dis-Chem typically
operates at slightly higher margin given its category mix.

4.2.3 Independent Pharmacies

The independent segment comprises approximately 1,500 pharmacy
outlets, mostly single-store operators or small regional chains.
Strengths include local relationships, neighbourhood positioning, and
clinical depth. Weaknesses are systemic: limited buying power, no
private label, weak technology, no loyalty infrastructure, and
capital-constrained owners approaching retirement age. This segment
represents both a competitive challenge (in geographies where they are
entrenched) and an acquisition / consolidation pipeline (a deliberate
Phase-4 opportunity for HealthPlus).

4.2.4 Supermarket-Anchored Pharmacies

Pick n Pay Pharmacy (approximately 200 outlets) and Medirite/Shoprite
(approximately 165 outlets) leverage parent-retailer foot traffic. They
offer convenience and price advantage on OTC items but lack standalone
brand strength, full-format clinical services, or beauty/wellness depth.
They compete primarily on price.

4.2.5 Buying Groups

Alpha Pharm and similar buying groups aggregate independents into a
shared procurement and private-label structure. They capture the
operational leverage that single independents lack, but member-owners
ultimately retain individual store decision rights, limiting strategic
agility.

4.3 Competitive Positioning Map

Figure 4.2

The positioning map above illustrates the strategic gap that
HealthPlus will occupy. The incumbent chains compete in the high-price,
high-reach quadrant. Independents occupy the high-price, mid-reach
quadrant due to weaker buying power. The supermarket-anchored players
sit at moderate price levels but have limited reach and category depth.
The low-price, high-reach quadrant — where customers in Tier 2/3 cities,
townships, and peri-urban nodes seek affordable healthcare access — is
structurally underserved.

4.4 Competitive Differentiation Framework

HealthPlus has been engineered with seven explicit differentiators
relative to incumbents:

4.5 SWOT Analysis

4.6 Barriers to Entry as Competitive Moat

While HealthPlus is itself a new entrant, the same barriers that we
are surmounting will protect the platform once established. Future
challengers will face:

• Multi-year SAPC, SAHPRA, and NHRPL licensing pathways for both
  retail and wholesale operations.
• Capital intensity: a credible national rollout requires R2.0–3.0
  billion of patient capital.
• Talent scarcity: South Africa produces approximately 750 newly
  qualified pharmacists per year — recruitment is the constraint, not
  facilities.
• Real estate access: prime township and high-traffic locations
  require incumbency and developer relationships.
• Brand-building cost: developing trusted private-label and store
  brand requires sustained investment over 3–5 years.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of HealthPlus Retail Group (Pty) Ltd.